Addiction Treatment Services

Addiction is a chronic disease, which causes individuals to seek “reward” from substance-use or other activities whether or not they may cause harm. Addiction treatment has been in the spotlight as payers, policymakers, and health systems struggle to address the opioid crisis and increasing substance-related mortality rates. As a result, the addiction treatment market is shifting—there is expanded coverage for residential treatment, a push towards greater integration and care coordination, and new competitors entering the market—creating new challenges and opportunities for organizations working in addiction treatment.

Latest Resources

• Federal Agencies Decline To Defend 2024 Mental Health Parity Rule & Prepare For New Proposal In 2026
• Public Comment Period Open For The Solano County, California Behavioral Health Services Act 2026-2029 Integrated Plan
• Wyoming Rebids Jail & Community Corrections IOP Addiction Treatment Contracts With July 2026 Start
• Qualifacts Acquires MethodOne To Fully Integrate Medication-Assisted Treatment Into Its EHR Platforms For Substance Use Disorder Provider Organizations
• WellStone Opens New Madison, Alabama Clinic For Adult Mental Health & Addiction Services
• Study Finds Adherence To Extended-Release Buprenorphine Associated With Lower Health Care Costs In Insured Adults With Opioid Use Disorder
• Everyone Wants Hybrid
• South Dakota Awards $7.8 Million From Opioid Settlement To 10 Projects To Combat Addiction By Closing Community Resource Gaps
• Half Of U.S. Jails Are More Than 30 Minutes From Opioid Treatment Programs, Limiting MOUD Access
• It’s The Engagement
• Review Finds Limited Evidence For Cannabis In Treating Mental Health Disorders
• Dazos’ New iCampaign Software Automates Email & SMS Marketing Programs To Boost Revenue For Treatment Centers & Behavioral Health Facilities
• Caron Treatment Centers Opens Outpatient Addiction Treatment Center In Delray Beach, Florida
• SimplePractice & Uprise Health Partner To Expand Digital Access To Behavioral Health Professionals
• The Productivity Pivot 

See All

GLP-1 Medications Linked To 15%–20% Lower Risk Of Substance Use Disorders In Veterans With Type 2 Diabetes

Researchers from the Veterans Affairs St. Louis Health Care System found that veterans with type 2 diabetes who were prescribed glucagon-like peptide-1 receptor agonists (GLP-1s) had a lower risk of developing substance use disorders (SUDs) compared to those prescribed sodium-glucose cotransporter-2 (SGLT-2) inhibitors, according to a study published in The BMJ. The study was conducted to examine whether GLP-1 medications—originally developed to treat type 2 diabetes and increasingly used for weight management—are associated with differences… Read

• California Awards $1.18 Billion In Bond Funding To Add 2,500+ Beds & 4,200+ Outpatient Slots
• Artemis Adolescent Healing Center Expands Teen Mental Health Services In Arizona
• GLP-1 Medications Linked To 15%–20% Lower Risk Of Substance Use Disorders In Veterans With Type 2 Diabetes
• Adolescent Cannabis Use Disorder Linked To 52% Higher Schizophrenia Risk Compared To Other Substance Use Disorders
• Private Equity Acquisition Of Addiction Treatment Facilities Linked To Higher Buprenorphine Use, Lower Treatment Retention

To sign-up for bi-weekly Mental Health alerts, you must be signed in to your account.